<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04124952</url>
  </required_header>
  <id_info>
    <org_study_id>AS-19-001</org_study_id>
    <nct_id>NCT04124952</nct_id>
  </id_info>
  <brief_title>Evaluation of Quality of Vision and Spectacle Independence With the AcrySof® Panoptix® Intraocular Lens</brief_title>
  <official_title>Evaluation of Quality of Vision and Spectacle Independence With Bilateral Implantation of the AcrySof® Panoptix® Intraocular Lens</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>SightTrust Eye Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Science in Vision</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>SightTrust Eye Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a study to assess the spectacle independence and quality of vision of patients&#xD;
      receiving the AcrySof® Panoptix® Intraocular lens (IOL) after uneventful cataract surgery.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is a single-arm unmasked clinical evaluation study of spectacle independence after&#xD;
      successful bilateral cataract surgery. Subjects will be assessed pre-operatively, operatively&#xD;
      and at 1 day, 1 month and 3 months post-operatively. Clinical evaluations will include&#xD;
      administration of a spectacle independence questionnaire, as well as measurement of bilateral&#xD;
      visual acuity and manifest refraction.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 3, 2019</start_date>
  <completion_date type="Actual">February 16, 2021</completion_date>
  <primary_completion_date type="Actual">February 16, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Emmetropic Subjects Who Are Spectacle Independent</measure>
    <time_frame>3 months</time_frame>
    <description>Number of patients who have a 3-month postoperative manifest spherical equivalent refraction within 0.5 diopters (D) of plano, and ≤ 0.5 D of refractive cylinder (emmetropic subgroup) who never or rarely wear spectacles for distance, intermediate or near vision 3 months postop (based on the Patient-Reported Spectacle Independence Questionnaire (PRSIQ) - &quot;a little of the time&quot; or &quot;none of the time&quot;).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Binocular Uncorrected Distance Visual Acuity</measure>
    <time_frame>3 months</time_frame>
    <description>Binocular logMAR uncorrected distance visual acuity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Binocular Uncorrected Intermediate Visual Acuity</measure>
    <time_frame>3 months</time_frame>
    <description>Binocular logMAR uncorrected intermediate visual acuity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Binocular Uncorrected Near Visual Acuity</measure>
    <time_frame>3 months</time_frame>
    <description>Binocular logMAR uncorrected near visual acuity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Binocular Corrected Distance Visual Acuity</measure>
    <time_frame>3 months</time_frame>
    <description>Binocular logMAR corrected distance visual acuity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Binocular Distance-corrected Intermediate Visual Acuity</measure>
    <time_frame>3 months</time_frame>
    <description>Binocular distance-corrected intermediate visual acuity in logMAR</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Binocular Distance-corrected Near Visual Acuity</measure>
    <time_frame>3 months</time_frame>
    <description>Binocular logMAR distance-corrected near visual acuity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Spherical Equivalent Refraction</measure>
    <time_frame>3 months</time_frame>
    <description>Spherical equivalent refraction in diopters</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Residual Refractive Cylinder</measure>
    <time_frame>3 months</time_frame>
    <description>Residual refractive cylinder in diopters</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Vision Questionnaire</measure>
    <time_frame>3 months</time_frame>
    <description>Quality of Vision questionnaire results. This is a Rasch-scaled test with scores from 0-100, with lower being better.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Overall Spectacle Independence</measure>
    <time_frame>3 months</time_frame>
    <description>percent of all patients who never or rarely wear spectacles for distance, intermediate or near vision 3 months postop (based on the PRSIQ - &quot;a little of the time&quot; or &quot;none of the time&quot;)</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">30</enrollment>
  <condition>Cataract</condition>
  <arm_group>
    <arm_group_label>Panoptix</arm_group_label>
    <description>Patients bilaterally implanted with the Panoptix intraocular lens.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Panoptix</intervention_name>
    <description>Alcon Acrysof(R) Panoptix(R) intraocular lens (IOL)</description>
    <arm_group_label>Panoptix</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Subjects ≥40 years of age presenting for cataract surgery who are interested in reducing&#xD;
        their dependence on spectacles at all distances, and who are appropriate candidates for&#xD;
        multifocal lens implantation.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria&#xD;
&#xD;
        Subjects are eligible for the study if they meet the following criteria:&#xD;
&#xD;
        Note: Ocular criteria must be met in both eyes.&#xD;
&#xD;
          -  Presenting for uncomplicated bilateral cataract surgery and have an interest in&#xD;
             spectacle independence using a multifocal IOL or multifocal toric IOL option&#xD;
&#xD;
          -  Gender: Males and Females.&#xD;
&#xD;
          -  Age: 40 or older.&#xD;
&#xD;
          -  Willing and able to provide written informed consent for participation in the study.&#xD;
&#xD;
          -  Willing and able to comply with scheduled visits and other study procedures.&#xD;
&#xD;
          -  Have good ocular health, with no pathology that compromises visual acuity (outside of&#xD;
             residual refractive error and cataract)&#xD;
&#xD;
          -  Have regular corneal astigmatism with a magnitude that can be treated with a non-toric&#xD;
             IOL or a toric IOL in the approved ranged for the Panoptix lens.&#xD;
&#xD;
          -  Have 20/32 (0.2 logMAR) or better potential acuity in both eyes&#xD;
&#xD;
        Exclusion Criteria If any of the following exclusion criteria are applicable to the subject&#xD;
        or either eye, the subject should not be enrolled in the study.&#xD;
&#xD;
          -  Irregular astigmatism (e.g. keratoconus)&#xD;
&#xD;
          -  Corneal pathology (e.g. scar, dystrophy, pterygium, severe dry eye)&#xD;
&#xD;
          -  Monocular status (e.g. amblyopia)&#xD;
&#xD;
          -  Previous radial keratotomy, corneal refractive surgery or other corneal surgery (e.g.&#xD;
             corneal transplant, lamellar keratoplasty)&#xD;
&#xD;
          -  Previous anterior or posterior chamber surgery (e.g., vitrectomy, laser iridotomy)&#xD;
&#xD;
          -  Diabetic retinopathy&#xD;
&#xD;
          -  Macular pathology (e.g. age-related macular degeneration, epiretinal membrane)&#xD;
&#xD;
          -  History of retinal detachment&#xD;
&#xD;
          -  Subjects who have an acute or chronic disease or illness that would confound the&#xD;
             results of this investigation (e.g., immunocompromised, connective tissue disease,&#xD;
             clinically significant atopic disease, diabetes, and any other such disease or&#xD;
             illness), that are known to affect postoperative visual acuity.&#xD;
&#xD;
          -  Participation in any investigational drug or device trial within the previous 30 days&#xD;
             prior to the start date of this trial (or currently participating).&#xD;
&#xD;
        The principal investigator reserves the right to declare a patient ineligible or&#xD;
        non-evaluable based on medical evidence that indicates they are unsuitable for the trial.&#xD;
&#xD;
        Pregnancy has a known effect on the stability of refractions and visual acuity. As such,&#xD;
        subjects who become pregnant during the study will not be discontinued but their data may&#xD;
        be excluded from analyses of effectiveness.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Andrew C Shatz, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>SightTrust Eye Institute</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>SightTrust Eye Institute</name>
      <address>
        <city>Sunrise</city>
        <state>Florida</state>
        <zip>33323</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Morlock R, Wirth RJ, Tally SR, Garufis C, Heichel CWD. Patient-Reported Spectacle Independence Questionnaire (PRSIQ): Development and Validation. Am J Ophthalmol. 2017 Jun;178:101-114. doi: 10.1016/j.ajo.2017.03.018. Epub 2017 Mar 22.</citation>
    <PMID>28341605</PMID>
  </reference>
  <reference>
    <citation>McAlinden C, Pesudovs K, Moore JE. The development of an instrument to measure quality of vision: the Quality of Vision (QoV) questionnaire. Invest Ophthalmol Vis Sci. 2010 Nov;51(11):5537-45. doi: 10.1167/iovs.10-5341. Epub 2010 May 26.</citation>
    <PMID>20505205</PMID>
  </reference>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>October 11, 2019</study_first_submitted>
  <study_first_submitted_qc>October 11, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 14, 2019</study_first_posted>
  <results_first_submitted>July 19, 2021</results_first_submitted>
  <results_first_submitted_qc>September 7, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">September 9, 2021</results_first_posted>
  <last_update_submitted>September 7, 2021</last_update_submitted>
  <last_update_submitted_qc>September 7, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Panoptix, trifocal IOL, multifocal IOL</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cataract</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>No current plans exist. If data are shared, they will be de-identified beforehand.</ipd_description>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>August 29, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/52/NCT04124952/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Panoptix</title>
          <description>Patients bilaterally implanted with the Panoptix intraocular lens.&#xD;
Panoptix: Alcon Acrysof(R) Panoptix(R) intraocular lens (IOL)</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="30"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="29"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Baseline data were for subjects completing the study</population>
      <group_list>
        <group group_id="B1">
          <title>Panoptix</title>
          <description>Patients bilaterally implanted with the Panoptix intraocular lens.&#xD;
Panoptix: Alcon Acrysof(R) Panoptix(R) intraocular lens (IOL)</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="29"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="29"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="58" spread="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="29"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="17"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="29"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Emmetropic Subjects Who Are Spectacle Independent</title>
        <description>Number of patients who have a 3-month postoperative manifest spherical equivalent refraction within 0.5 diopters (D) of plano, and ≤ 0.5 D of refractive cylinder (emmetropic subgroup) who never or rarely wear spectacles for distance, intermediate or near vision 3 months postop (based on the Patient-Reported Spectacle Independence Questionnaire (PRSIQ) - &quot;a little of the time&quot; or &quot;none of the time&quot;).</description>
        <time_frame>3 months</time_frame>
        <population>This is the number of emmetropic subjects (subgroup)</population>
        <group_list>
          <group group_id="O1">
            <title>Panoptix</title>
            <description>Patients bilaterally implanted with the Panoptix intraocular lens.&#xD;
Panoptix: Alcon Acrysof(R) Panoptix(R) intraocular lens (IOL)</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Emmetropic Subjects Who Are Spectacle Independent</title>
          <description>Number of patients who have a 3-month postoperative manifest spherical equivalent refraction within 0.5 diopters (D) of plano, and ≤ 0.5 D of refractive cylinder (emmetropic subgroup) who never or rarely wear spectacles for distance, intermediate or near vision 3 months postop (based on the Patient-Reported Spectacle Independence Questionnaire (PRSIQ) - &quot;a little of the time&quot; or &quot;none of the time&quot;).</description>
          <population>This is the number of emmetropic subjects (subgroup)</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="21"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Binocular Uncorrected Distance Visual Acuity</title>
        <description>Binocular logMAR uncorrected distance visual acuity</description>
        <time_frame>3 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Panoptix</title>
            <description>Patients bilaterally implanted with the Panoptix intraocular lens.&#xD;
Panoptix: Alcon Acrysof(R) Panoptix(R) intraocular lens (IOL)</description>
          </group>
        </group_list>
        <measure>
          <title>Binocular Uncorrected Distance Visual Acuity</title>
          <description>Binocular logMAR uncorrected distance visual acuity</description>
          <units>logMAR</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="29"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.07" spread="0.09"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Binocular Uncorrected Intermediate Visual Acuity</title>
        <description>Binocular logMAR uncorrected intermediate visual acuity</description>
        <time_frame>3 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Panoptix</title>
            <description>Patients bilaterally implanted with the Panoptix intraocular lens.&#xD;
Panoptix: Alcon Acrysof(R) Panoptix(R) intraocular lens (IOL)</description>
          </group>
        </group_list>
        <measure>
          <title>Binocular Uncorrected Intermediate Visual Acuity</title>
          <description>Binocular logMAR uncorrected intermediate visual acuity</description>
          <units>logMAR</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="29"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.09" spread="0.13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Binocular Uncorrected Near Visual Acuity</title>
        <description>Binocular logMAR uncorrected near visual acuity</description>
        <time_frame>3 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Panoptix</title>
            <description>Patients bilaterally implanted with the Panoptix intraocular lens.&#xD;
Panoptix: Alcon Acrysof(R) Panoptix(R) intraocular lens (IOL)</description>
          </group>
        </group_list>
        <measure>
          <title>Binocular Uncorrected Near Visual Acuity</title>
          <description>Binocular logMAR uncorrected near visual acuity</description>
          <units>logMAR Acuity</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="29"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.07" spread="0.11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Binocular Corrected Distance Visual Acuity</title>
        <description>Binocular logMAR corrected distance visual acuity</description>
        <time_frame>3 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Panoptix</title>
            <description>Patients bilaterally implanted with the Panoptix intraocular lens.&#xD;
Panoptix: Alcon Acrysof(R) Panoptix(R) intraocular lens (IOL)</description>
          </group>
        </group_list>
        <measure>
          <title>Binocular Corrected Distance Visual Acuity</title>
          <description>Binocular logMAR corrected distance visual acuity</description>
          <units>logMAR Acuity</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="29"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.03" spread="0.07"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Binocular Distance-corrected Intermediate Visual Acuity</title>
        <description>Binocular distance-corrected intermediate visual acuity in logMAR</description>
        <time_frame>3 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Panoptix</title>
            <description>Patients bilaterally implanted with the Panoptix intraocular lens.&#xD;
Panoptix: Alcon Acrysof(R) Panoptix(R) intraocular lens (IOL)</description>
          </group>
        </group_list>
        <measure>
          <title>Binocular Distance-corrected Intermediate Visual Acuity</title>
          <description>Binocular distance-corrected intermediate visual acuity in logMAR</description>
          <units>logMAR Acuity</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="29"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.06" spread="0.10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Binocular Distance-corrected Near Visual Acuity</title>
        <description>Binocular logMAR distance-corrected near visual acuity</description>
        <time_frame>3 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Panoptix</title>
            <description>Patients bilaterally implanted with the Panoptix intraocular lens.&#xD;
Panoptix: Alcon Acrysof(R) Panoptix(R) intraocular lens (IOL)</description>
          </group>
        </group_list>
        <measure>
          <title>Binocular Distance-corrected Near Visual Acuity</title>
          <description>Binocular logMAR distance-corrected near visual acuity</description>
          <units>logMAR Acuity</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="29"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.05" spread="0.11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Spherical Equivalent Refraction</title>
        <description>Spherical equivalent refraction in diopters</description>
        <time_frame>3 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Panoptix</title>
            <description>Patients bilaterally implanted with the Panoptix intraocular lens.&#xD;
Panoptix: Alcon Acrysof(R) Panoptix(R) intraocular lens (IOL)</description>
          </group>
        </group_list>
        <measure>
          <title>Spherical Equivalent Refraction</title>
          <description>Spherical equivalent refraction in diopters</description>
          <units>diopters</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="29"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.06" spread="0.53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Residual Refractive Cylinder</title>
        <description>Residual refractive cylinder in diopters</description>
        <time_frame>3 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Panoptix</title>
            <description>Patients bilaterally implanted with the Panoptix intraocular lens.&#xD;
Panoptix: Alcon Acrysof(R) Panoptix(R) intraocular lens (IOL)</description>
          </group>
        </group_list>
        <measure>
          <title>Residual Refractive Cylinder</title>
          <description>Residual refractive cylinder in diopters</description>
          <units>diopters</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="29"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.49" spread="0.36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Quality of Vision Questionnaire</title>
        <description>Quality of Vision questionnaire results. This is a Rasch-scaled test with scores from 0-100, with lower being better.</description>
        <time_frame>3 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Panoptix</title>
            <description>Patients bilaterally implanted with the Panoptix intraocular lens.&#xD;
Panoptix: Alcon Acrysof(R) Panoptix(R) intraocular lens (IOL)</description>
          </group>
        </group_list>
        <measure>
          <title>Quality of Vision Questionnaire</title>
          <description>Quality of Vision questionnaire results. This is a Rasch-scaled test with scores from 0-100, with lower being better.</description>
          <units>Score on a scale (0-100, 0 is best)</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="29"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Frequency</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="36.9" spread="16.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Severity</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="30.6" spread="15.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Degree of bother</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="28.7" spread="20.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Overall Spectacle Independence</title>
        <description>percent of all patients who never or rarely wear spectacles for distance, intermediate or near vision 3 months postop (based on the PRSIQ - &quot;a little of the time&quot; or &quot;none of the time&quot;)</description>
        <time_frame>3 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Panoptix</title>
            <description>Patients bilaterally implanted with the Panoptix intraocular lens.&#xD;
Panoptix: Alcon Acrysof(R) Panoptix(R) intraocular lens (IOL)</description>
          </group>
        </group_list>
        <measure>
          <title>Overall Spectacle Independence</title>
          <description>percent of all patients who never or rarely wear spectacles for distance, intermediate or near vision 3 months postop (based on the PRSIQ - &quot;a little of the time&quot; or &quot;none of the time&quot;)</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="29"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>3 months</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Panoptix</title>
          <description>Patients bilaterally implanted with the Panoptix intraocular lens.&#xD;
Panoptix: Alcon Acrysof(R) Panoptix(R) intraocular lens (IOL)</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="30"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="30"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="30"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Bicycle accident</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="30"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Andrew Shatz, MD</name_or_title>
      <organization>SightTrust Eye Institute</organization>
      <phone>877.878.7890</phone>
      <email>ashatz@sighttrust.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

